JAMES BLEDSOE: Open Payments
NPI 1508902321 · CORRIGAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 48 payments from 11 companies in 2025. Trend: 2023 $958 · 2024 $1,144 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $363 |
| Novo Nordisk Inc | 10 | $169 |
| GlaxoSmithKline, LLC. | 8 | $157 |
| ABBVIE INC. | 2 | $115 |
| Astellas Pharma US Inc | 4 | $86 |
| Inspire Medical Systems, Inc. | 1 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, Ozempic, UBRELVY, FARXIGA, Veozah, INSPIRE.
Industry payments across TX — which companies pay providers there.
